Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Critical Care (London, England)|July 12, 2014
Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational studyMichael Zoller, Barbara Maier, Cyrill Hornuss, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 18, 2012
Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapyOliver J Stoetzer, Debora M I Fersching, Christoph Salat, et al.
Plos One|October 17, 2012
Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohortMark op den Winkel, Dorothea Nagel, Julia Sappl, et al.
Annals of the New York Academy of Sciences|October 8, 2008
Clinical relevance of circulating nucleosomes in cancerStefan Holdenrieder, Dorothea Nagel, Andreas Schalhorn, et al.
Clinical Chemistry and Laboratory Medicine|March 15, 2003
Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassayThomas Muley, Werner Ebert, Petra Stieber, et al.
Digestive Diseases (Basel, Switzerland)|April 14, 2022
Development and External Validation of the Munich Sorafenib Evaluation Score for Hepatocellular CarcinomaMark Op den Winkel, Dorothea Nagel, Max Seidensticker, et al.
Digestion|October 4, 2018
The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular CarcinomaMark Op den Winkel, Dorothea Nagel, Philip Op den Winkel, et al.
Digestive Diseases (Basel, Switzerland)|June 10, 2021
A Simple Prognostic Scoring System for Hepatocellular Carcinoma Treated with Selective Internal Radiation TherapyMark Op den Winkel, Dorothea Nagel, Manuel A de la Torre Aláez, et al.
International Journal of Cancer|January 27, 2017
Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancerAndreas Herbst, Nikolay Vdovin, Sanja Gacesa, et al.
Clinical Laboratory|February 21, 2003
Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patientsPetra Stieber, Rafael Molina, Daniel W Chan, et al.
Pageof 8